within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01F_MacrolidesLincosamidesAndStreptogramins.J01FG02_QuinupristinDalfopristin;

model QuinupristinDalfopristin
  extends Pharmacolibrary.Drugs.ATC.J.J01FG02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01FG02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Quinupristin/dalfopristin is a combination of two streptogramin antibiotics. It acts synergistically to inhibit bacterial protein synthesis and is used primarily in the treatment of serious infections caused by multidrug-resistant Gram-positive organisms, including vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus. It is approved for clinical use in certain countries but its use has become limited due to adverse effects and availability of alternative agents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Bearden, DT (2004). Clinical pharmacokinetics of quinupristin/dalfopristin. <i>Clinical pharmacokinetics</i> 43(4) 239–252. DOI:<a href=\"https://doi.org/10.2165/00003088-200443040-00003\">10.2165/00003088-200443040-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15005638/\">https://pubmed.ncbi.nlm.nih.gov/15005638</a></p></li><li><p>Bergeron, M, &amp; Montay, G (1997). The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans. <i>The Journal of antimicrobial chemotherapy</i> 39 Suppl A 129–138. DOI:<a href=\"https://doi.org/10.1093/jac/39.suppl_1.129\">10.1093/jac/39.suppl_1.129</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9511077/\">https://pubmed.ncbi.nlm.nih.gov/9511077</a></p></li><li><p>Chevalier, P, et al., &amp; Montay, G (2000). Pharmacokinetics of quinupristin/ dalfopristin in patients with severe chronic renal insufficiency. <i>Clinical pharmacokinetics</i> 39(1) 77–84. DOI:<a href=\"https://doi.org/10.2165/00003088-200039010-00005\">10.2165/00003088-200039010-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10926351/\">https://pubmed.ncbi.nlm.nih.gov/10926351</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end QuinupristinDalfopristin;
